MedTrace Logo

PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial

NCT02594241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2020-09-29

No results posted yet for this study

Summary

Patients who undergo abdominal wall reconstruction for giant ventral hernia repair will be randomized to either methylprednisolone or saline preoperatively, to examine the effects of methylprednisolone on postoperative pain, nausea and recovery after giant ventral hernia repair.

Conditions

  • Hernia, Ventral

Interventions

DRUG

Methyl-Prednisolone

Single-shot 125 mg infusion given immediately after induction of anesthesia.

DRUG

Physiological saline

A single preoperative dosage 100 ml given intravenously as a 30 minute infusion, 2 hours before surgery

Sponsors & Collaborators

  • Kristian Kiim Jensen

    lead OTHER

Principal Investigators

  • Kristian K Jensen, MD · Bispebjerg Hospital, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2018-05-31
Completion
2018-11-30

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02594241 on ClinicalTrials.gov